| 0 (0%) | 01-14 09:38 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 21.5 | 1-year : | 24.01 |
| Resists | First : | 18.41 | Second : | 20.55 |
| Pivot price | 15.96  |
|||
| Supports | First : | 14.93 | Second : | 12.43 |
| MAs | MA(5) : | 15.53  |
MA(20) : | 16.5 |
| MA(100) : | 20.96 |
MA(250) : | 25.18 |
|
| MACD | MACD : | -0.7 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 20.4 |
D(3) : | 14.7 |
| RSI | RSI(14): 41.8 |
|||
| 52-week | High : | 69.97 | Low : | 6.76 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ TNXP ] has closed above bottom band by 36.0%. Bollinger Bands are 75.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 15.76 - 15.84 | 15.84 - 15.91 |
| Low: | 14.98 - 15.07 | 15.07 - 15.15 |
| Close: | 15.47 - 15.64 | 15.64 - 15.77 |
Mon, 22 Dec 2025
Noble Financial Has Positive Outlook of TNXP FY2025 Earnings - MarketBeat
Tue, 16 Dec 2025
(TNXP) Risk Channels and Responsive Allocation - Stock Traders Daily
Thu, 11 Dec 2025
Equities Analysts Offer Predictions for TNXP FY2025 Earnings - MarketBeat
Tue, 09 Dec 2025
Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel - Stock Titan
Mon, 08 Dec 2025
TNXP: Tonix Now a Commercial Stage Company Following the Launch of Tonmya™ - Yahoo Finance
Mon, 01 Dec 2025
Will Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Spend Its Cash Wisely? - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 12 (M) |
| Held by Insiders | 1.115e+007 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 1,940 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -9.746e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 5 % |
| Return on Equity (ttm) | -36 % |
| Qtrly Rev. Growth | 1.03e+007 % |
| Gross Profit (p.s.) | 9.07 |
| Sales Per Share | -35.52 |
| EBITDA (p.s.) | 1.92896e+006 |
| Qtrly Earnings Growth | 279.1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -75 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.45 |
| Price to Cash Flow | 1.25 |
| Dividend | 0 |
| Forward Dividend | 2.22e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|